Chinese biopharma firm EOC Pharma snags $71m in Series C round

Retrieved on: 2019-12-01 16:03:45

Tags for this article:

Click the tags to see associated articles and topics

Chinese biopharma firm EOC Pharma snags $71m in Series C round. View article details on hiswai:

Excerpt

<div>EOC had last raised $32 million in a Series B round in 2017 from Taikang Investment, <b>Sequoia Capital</b> China, and H&Q Asia Pacific. EOC was spun ...</div>

Article found on:

View Original Article